Effects of 2-Br-alpha-Ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy; D001966:Bromine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002940:Circadian Rhythm; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007094:Imides / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008593:Menopause; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*
D004876:Ergot Alkaloids; D007094:Imides; D004295:Dihydroxyphenylalanine; D011388:Prolactin; D001966:Bromine